Suppr超能文献

保罗·埃尔利希(1854 - 1915)及其对转化医学基础与诞生的贡献。

Paul Ehrlich (1854-1915) and His Contributions to the Foundation and Birth of Translational Medicine.

作者信息

Valent Peter, Groner Bernd, Schumacher Udo, Superti-Furga Giulio, Busslinger Meinrad, Kralovics Robert, Zielinski Christoph, Penninger Josef M, Kerjaschki Dontscho, Stingl Georg, Smolen Josef S, Valenta Rudolf, Lassmann Hans, Kovar Heinrich, Jäger Ulrich, Kornek Gabriela, Müller Markus, Sörgel Fritz

机构信息

Department of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.

出版信息

J Innate Immun. 2016;8(2):111-20. doi: 10.1159/000443526. Epub 2016 Feb 5.

Abstract

Translational research and precision medicine are based on a profound knowledge of cellular and molecular mechanisms contributing to various physiologic processes and pathologic reactions in diverse organs. Whereas specific molecular interactions and mechanisms have been identified during the past 5 decades, the underlying principles were defined much earlier and originate from to the seminal observations made by outstanding researchers between 1850 and 1915. One of the most outstanding exponents of these scientists is Paul Ehrlich. His work resulted not only in the foundation and birth of modern hematology and immunology, but also led to the development of chemotherapy and specific targeted treatment concepts. In 2015, the Medical University of Vienna organized a memorial meeting, with the aim of honoring Paul Ehrlich's contributions to science, and to commemorate the 100th anniversary of his death. The authors of the current review served as faculty members and dedicate this paper to Paul Ehrlich and his remarkable contributions to medicine.

摘要

转化医学和精准医学基于对细胞和分子机制的深入了解,这些机制促成了不同器官中的各种生理过程和病理反应。尽管在过去50年中已经确定了特定的分子相互作用和机制,但基本原理的定义要早得多,可追溯到1850年至1915年间杰出研究人员的开创性观察。这些科学家中最杰出的代表之一是保罗·埃尔利希。他的工作不仅奠定了现代血液学和免疫学的基础并使其诞生,还推动了化疗和特异性靶向治疗概念的发展。2015年,维也纳医科大学组织了一次纪念会议,旨在表彰保罗·埃尔利希对科学的贡献,并纪念他逝世100周年。本综述的作者作为教员,将本文献给保罗·埃尔利希及其对医学的卓越贡献。

相似文献

7
The contributions of Paul Ehrlich to infectious disease.保罗·埃尔利希对传染病的贡献。
J Infect. 2007 Mar;54(3):221-4. doi: 10.1016/j.jinf.2004.05.022. Epub 2006 Mar 29.

引用本文的文献

8
William Coley: The Pioneer and the Father of Immunotherapy.威廉·科利:免疫疗法的先驱与之父。
Cureus. 2024 Sep 10;16(9):e69113. doi: 10.7759/cureus.69113. eCollection 2024 Sep.

本文引用的文献

6
Paul Ehrlich: founder of chemotherapy.保罗·埃尔利希:化疗的创始人。
Nat Rev Drug Discov. 2008 May;7(5):373. doi: 10.1038/nrd2582.
9
Case histories, magic bullets and the state of drug discovery.病例史、神奇药物与药物研发现状
Nat Rev Drug Discov. 2006 Aug;5(8):635-40. doi: 10.1038/nrd2084. Epub 2006 Apr 13.
10
The contributions of Paul Ehrlich to infectious disease.保罗·埃尔利希对传染病的贡献。
J Infect. 2007 Mar;54(3):221-4. doi: 10.1016/j.jinf.2004.05.022. Epub 2006 Mar 29.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验